Cardiac surgery in patients with Hemophilia:is it safe?

The life expectancy of hemophiliacs is similar to that of the general population. As a result, the prevalence of age-related cardiovascular diseases has increased. We present our experience with hemophilia patients who underwent cardiac surgery in our Medical Center between 2004 and 2019. All hemoph...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of cardiothoracic surgery 2020-05, Vol.15 (1), p.76-76, Article 76
Main Authors:	Shalabi, Amjad, Kachel, Erez, Kogan, Alexander, Sternik, Leonid, Grosman-Rimon, Liza, Ben-Avi, Ronny, Ghanem, Diab, Ram, Eilon, Raanani, Ehud, Misgav, Mudi
Format:	Article
Language:	eng
Subjects:	Adult Age Aged Aorta Aortic valve Bleeding Bypass Cardiac patients Cardiac surgery Cardiac Surgical Procedures - mortality Cardiovascular disease Cardiovascular diseases Care and treatment Clinical outcomes Coagulation factors Coronary artery Coronary artery bypass Factor IX Factor VIII Factor XI deficiency Factor XI Deficiency - complications Female Health aspects Health care facilities Heart Heart Diseases - complications Heart Diseases - surgery Heart surgery Heart valves Hemophilia Hemophilia a Hemophilia A - complications Hemophilia B Hemophilia B - complications Humans Life expectancy Life span Male Medical centers Middle Aged Patients Perioperative Care - methods Postoperative Complications - diagnosis Postoperative Complications - etiology Postoperative Complications - therapy Retrospective Studies Surgery Syngeneic grafts Weaning
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The life expectancy of hemophiliacs is similar to that of the general population. As a result, the prevalence of age-related cardiovascular diseases has increased. We present our experience with hemophilia patients who underwent cardiac surgery in our Medical Center between 2004 and 2019. All hemophilia patients who underwent cardiac surgery were identified, and their peri-operative data evaluated retrospectively. Ten patients were identified: six with hemophilia-A, one with hemophilia-B, and three with hemophilia-C (factor XI deficiency). Cardiac procedures included ten coronary artery bypass grafts and one aortic valve replacement. Hemophilia-A and B patients were treated with factor substitution, whereas patients with factor XI deficiency were treated with fresh frozen plasma. One patient died, and one patient suffered from non-active gastrointestinal bleeding. While major cardiac surgery can be performed safely on patients with hemophilia, a multidisciplinary team approach and strict postoperative monitoring are essential in order to achieve optimal results.
ISSN:	1749-8090 1749-8090